文献速递青光眼

Cav1缺陷小鼠中NOS3缺失降低对一氧化氮供体及两种一氧化氮合酶抑制剂的药物敏感性

NOS3 Deletion in Cav1 Deficient Mice Decreases Drug Sensitivity to a Nitric Oxide Donor and Two Nitric Oxide Synthase Inhibitors.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究在Cav1敲除小鼠中进一步敲除NOS3(双敲除),观察局部给予一氧化氮供体SNP及两种NOS抑制剂的降眼压反应。双敲除小鼠对SNP和L-NAME的敏感性降低,cGMP活性显著低于Cav1单敲除小鼠,提示NOS/cGMP通路受损可能介导此药效改变。

要点

  • 双敲除小鼠中iNOS表达较野生型、Cav1敲除及NOS3敲除小鼠显著增加。
  • 双敲除小鼠中SNP需达40 mg/mL才显著降眼压14%(n=8,P<0.01),30 mg/mL及以下无效。
  • 双敲除小鼠中仅200 μM L-NAME显著升高眼压(n=10,P<0.05),cGMP活性显著低于Cav1敲除小鼠(n=4,P<0.05)。

核心结论

  • Cav1缺陷小鼠中NOS3基因缺失导致对NO供体SNP和两种NOS抑制剂的敏感性降低,可能源于NOS和cGMP活性受损。

研究设计与样本

  • 研究为动物实验,比较双敲除(DKO)、野生型(WT)、Cav1敲除(Cav1 KO)和NOS3敲除(NOS3 KO)小鼠。
  • 局部眼表给予SNP(10-40 mg/mL)、L-NAME(10-200 μM)或cavtratin(10-75 μM),对侧眼为溶剂对照。
  • 用眼压计测量双眼眼压,ELISA法测定房水流出组织cGMP水平,western blot分析蛋白表达。

主要发现

  • 双敲除小鼠iNOS表达较WT、Cav1 KO和NOS3 KO小鼠显著增加。
  • 与WT、Cav1 KO和NOS3 KO小鼠不同,双敲除小鼠中SNP浓度达30 mg/mL对眼压无显著影响。
  • 双敲除小鼠中SNP 40 mg/mL显著降低眼压14%(n=8,P<0.01)。
  • 双敲除小鼠中仅200 μM L-NAME显著升高眼压(n=10,P<0.05)。
  • cavtratin在双敲除和NOS3 KO小鼠中均未显著改变眼压。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to investigate the pharmacologic consequence of genetic deletion of nitric oxide synthase 3 (NOS3) in caveolin 1 (Cav1)-/- mice (double knockout [DKO]) in response to a nitric oxide (NO) donor and two NOS inhibitors. METHODS: NO donor sodium nitroprusside (SNP; 10-40 mg/mL), NOS inhibitor L-NG-nitroarginine methyl ester (L-NAME; 10-200 μM), and cavtratin (10-75 μM ) was administered topically to the eye while the contralateral eyes were vehicle controls. Intraocular pressure (IOP) was measured in both eyes by tonometry. Cyclic guanosine monophosphate (cGMP) level in outflow tissue was measured by ELISA assay. Protein expression were analyzed by western blot. RESULTS: Inducible NOS (iNOS) expression significantly increased in the DKO mice compared with the wild type (WT), Cav1 knockout (Cav1 KO), and NOS3 KO mice. In contrast to WT, Cav1 KO and NOS3 KO mice, SNP concentration of up to 30 mg/mL did not significantly affect IOP in DKO mice. However, higher concentration (40 mg/mL) SNP significantly reduced IOP by 14% (n = 8, P < 0.01). Similarly, only 200 μM L-NAME produced a significant increase in IOP (n = 10, P < 0.05). Cavtratin did not significantly change IOP in DKO and NOS3 KO mice. cGMP activity in DKO mice was significantly lower than Cav1 KO mice (n = 4, P < 0.05). CONCLUSIONS: In conclusion, our results demonstrated that genetic deletion of NOS3 in Cav1 deficient mice resulted in reduced sensitivity to the NO donor SNP and the two NOS inhibitors possibly due to compromised NOS and cGMP activity.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Song M, Li L, Lei Y, et al. NOS3 Deletion in Cav1 Deficient Mice Decreases Drug Sensitivity to a Nitric Oxide Donor and Two Nitric Oxide Synthase Inhibitors. Invest Ophthalmol Vis Sci. 2019. PMID: 31560766. doi:10.1167/iovs.19-27582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。